| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| AN2 Therapeutics, Inc. | Chief Medical Officer | Common Stock | 51,416 | $982,771 | $19.11 | 15 Mar 2024 | Direct |
| AN2 Therapeutics, Inc. | Chief Medical Officer | Stock Option (right to buy) | 60,000 | 15 Mar 2024 | Direct | ||
| AN2 Therapeutics, Inc. | Chief Medical Officer | Common | 51,416 | 15 Mar 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ANTX | AN2 Therapeutics, Inc. | 15 Mar 2024 | 1 | $0 | 4/A | Chief Medical Officer | 29 Mar 2024, 16:19 |
| ANTX | AN2 Therapeutics, Inc. | 15 Mar 2024 | 2 | $0 | 4 | Chief Medical Officer | 18 Mar 2024, 19:27 |
| ANTX | AN2 Therapeutics, Inc. | 15 Feb 2023 | 1 | $0 | 4 | Chief Medical Officer | 17 Feb 2023, 18:25 |
| ANTX | AN2 Therapeutics, Inc. | 12 May 2022 | 1 | $0 | 4 | Chief Medical Officer | 16 May 2022, 21:23 |
| ANTX | AN2 Therapeutics, Inc. | 24 Mar 2022 | 0 | $0 | 3 | Chief Medical Officer | 24 Mar 2022, 21:25 |